SGLT2i: beyond the glucose-lowering effect

SGLT2i: beyond the glucose-lowering effect

Abstract Sodium/glucose cotransporter-2 inhibitors (SGLT2i) are a new type of glucose-lowering drug that can reduce blood glucose by inhibiting its reabsorption in proximal tubules and by promoting urinary glucose excretion. SGLT2i are widely used in the clinical treatment of type 2 diabetes mellitu...

Full description

Bibliographic Details
Main Authors: Lihua Ni, Cheng Yuan, Guopeng Chen, Changjiang Zhang, Xiaoyan Wu
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Cardiovascular Diabetology
Subjects:
Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
Type 2 diabetes
Cardiovascular disease
Renal disease
Online Access:http://link.springer.com/article/10.1186/s12933-020-01071-y

Internet

http://link.springer.com/article/10.1186/s12933-020-01071-y

Similar Items